Raamsdonksveer, Netherlands / Potsdam, Germany, 28 February 2025 – The Dopharma Group and its fully owned subsidiary Ripac-Labor GmbH, are pleased to announce the official ground-breaking of their new state-of-the-art production facility for autogenous vaccines in Potsdam, Germany. This took place in the presence of Mike Schubert (Lord mayor of Potsdam), Wijnand de Bruijn (CEO Business […]
